SlideShare ist ein Scribd-Unternehmen logo
1 von 27
Downloaden Sie, um offline zu lesen
Introduction Background Results Mechanisms Conclusions
More hips, please. Independent sector provision and the
growth in NHS-funded elective care
Elaine Kelly & George Stoye
Nueld Trust Workshop
13th September 2013
1/27
Introduction Background Results Mechanisms Conclusions
Introduction
The past decade of health care policy reforms have increased the role of
competition in NHS-funded care.
Existing work has concentrated on the patient choice reforms of 2006
and 2008. [Cooper et al, 2011; Gaynor et al, 2012 a,b]
This paper focuses on a separate but related set of reforms that
increased the access of independent sector providers (ISP) to markets for
NHS-funded elective secondary care.
How did this aect the market for both NHS and privately funded hip
replacements?
2/27
Figure : Total number of NHS-funded hip replacements in England, by provider type
0
10,000
20,000
30,000
40,000
50,000
60,000
70,000
80,000
HipReplacements
Financial Year
ISP NHS Trusts
The total number of NHS-funded hip replacements increased by 40% between
2003/04 and 2010/11.
After 2006/07, most of this growth is accounted for by ISPs.
Figure : Mean hip NHS-funded replacements per Middle Super Output Area by
nearest provider type in 2010/11
6
6.5
7
7.5
8
8.5
9
9.5
10
10.5
11
2003/4 2004/5 2005/6 2006/7 2007/8 2008/9 2009/10 2010/11
MeanhipreplacementsperMOSA/year
NHS ISP
Growth was fastest in areas where an ISP was located closer than the nearest NHS
trust by 2010/11.
Introduction Background Results Mechanisms Conclusions
Research Questions
How did the introduction of ISPs aect the market for NHS-funded hip
replacements?
1 Why did the number of hip replacements increase faster in areas where
ISPs were located relatively close by?
2 What explains the increase in the number of NHS-funded hip
replacements?
New procedures
Substitution from privately funded procedures
5/27
Introduction Background Results Mechanisms Conclusions
Independent Sector Provider reforms
1 Independent Sector Treatment Centres (ISTCs)
First introduced in 2003, expanded in 2006.
Privately owned but typically treat just NHS-funded patients.
Objectives [Naylor  Gregory, 2009]:
Wave 1: to address capacity constraints and reduce waiting times
Wave 2: increasing competition for NHS providers, providing more choices
for patients, and fostering innovation.
2 Any Qualied Providers (AQPs)
In mid 2007, choice of providers in orthopaedics expanded to cover
existing facilities, such as private hospitals, through the Extended Choice
Network.
Treat privately funded and NHS-funded patients.
Extended to other specialties when 2nd choice reform was introduced in
2008.
6/27
Figure : NHS-funded hip replacements conducted by ISPs, by quarter and ISP type
0500100015002000
NumberISPHipProcedures
2003q2
2004q2
2005q2
2006q2
2007q2
2008q2
2009q2
2010q2
2011q2
Time
ISTC sites AQP sites
ISTC volumes started to increase as ISTCs began to open. Levelled o after 2008.
AQP volumes increased rapidly after the second choice reform was introduced.
Figure : Number of ISP sites by year and ISP type
0
20
40
60
80
100
120
Sites 1 pat Sites 20 pats Sites 1 pat Sites 20 pats
ISTC AQP
NumberofISPSites
2003/4
2004/5
2005/6
2006/7
2007/8
2008/9
2009/10
2010/11
More AQP sites, but ISTC procedures more concentrated across sites.
In 2010/11, average NHS-funded hip replacements per site were 65 for AQPs and
160 for ISTCs.
Figure : Mean number of hip replacements per MSOA/year, by nearest provider
type in 2010/11
6
6.5
7
7.5
8
8.5
9
9.5
10
10.5
11
2003/4 2004/5 2005/6 2006/7 2007/8 2008/9 2009/10 2010/11
MeanhipreplacementsperMSOA/year
Financial Year
NHS ISTC AQP
Relative growth is much faster in areas where an ISTC is the nearest provider than
where AQPs are the nearest provider.
Shift in entire distribution, not just the mean.
Introduction Background Results Mechanisms Conclusions
Why might introducing ISPs aect the number of
NHS-funded procedures?
1 Supply: extra potential capacity relaxes supply constraints.
An initial objective of the ISTC programme [Naylor  Gregory, 2009]
2 Demand: ISPs provide an option that potential patients prefer to:
1 No procedure.
2 Privately funded treatment
This paper focuses on establishing whether there was a demand response.
Diculty: all areas/patients can access ISPs through the 2008 choice
reforms.
Solution: exploit variation in intensity of treatment or exposure by
relative distance between the nearest ISP and the nearest NHS trust.
10/27
Introduction Background Results Mechanisms Conclusions
Why does the growth rate of hip replacement vary by
distance to ISP?
1 Endogenous placement: ISPs located in areas where higher growth is
anticipated/removing supply constraints
2 A demand response:
Patients prefer treatment closer to home [Beckert et al, 2012; Sivey 2012].
Analysis examines ISP placement and the number of hip replacements at
the Middle Super Output Area (MSOA) level.
Data on NHS-funded hip replacements from the inpatient Hospital
Episode Statistics (HES).
6,710 MSOAs in England (ave pop 7,200). MSOAs are a statistical
construct, no administrative jurisdictions.
Dene MSOA as treated if there is an ISP that performs hip
replacements nearer than the NHS trust.
11/27
Introduction Background Results Mechanisms Conclusions
What are the determinants of ISP placement?
The odds of MSOA m having an ISP closer than the nearest NHS trust in
2010/11 is given by the following specication:
ISPclose10m = θo +θ1WaitTimesm +θ2nTrustm +θ3SDm +em (1)
WaitTimesm includes waiting times of nearest trust and residents of the
MSOA, and MSOA admittances for hip replacements in 2003/04.
nTrustm are characteristics of the nearest trust to MSOA m; SDm are
socio-demographic characteristics (all pre 2005)
Results aim to indicate:
The extent to which ISP placement reects population need/supply
constraints
Any sources of random variation in placement that could be used for
identication
12/27
Table : Odds of having an ISP closer than the nearest NHS trust in 2010/11
Type of ISP Closer than the Nearest Trust
ISP ISP ISP ISTC only AQP only
(1) (2) (3) (4) (5)
Nearest Trust Wait Time 2003 (SD) 1.352*** 1.195** 1.141 1.284 1.124
(0.102) (0.0900) (0.117) (0.272) (0.128)
MSOA Wait Time 2003 (SD) 0.983 0.963 0.943 0.927 0.955
(0.0356) (0.0355) (0.0451) (0.0742) (0.0493)
Average hip replacements in 2003 and 2004 0.972* 0.927*** 0.939** 1.013 0.938**
(0.0159) (0.0176) (0.0242) (0.0370) (0.0257)
Distance to Nearest Trust (km) 1.120*** 1.078*** 1.054 1.064**
(0.0270) (0.0294) (0.0408) (0.0300)
Distance to Nearest Trust Squared (km) 0.997*** 0.998** 0.999 0.999
(0.000760) (0.000768) (0.000941) (0.000789)
IMD score (2004) 0.967*** 0.976 1.063*** 0.941***
(0.0117) (0.0179) (0.0185) (0.0198)
Private hospital closer 29.25*** 3.573*** 33.56***
(7.843) (1.292) (9.935)
NHS `hospital' (30 beds) closer 2.028*** 2.146*** 1.915***
(0.384) (0.624) (0.386)
Nearest trust  Socio-demographics No Yes Yes Yes Yes
Observations 6,710 6,710 6,710 6,710 6,710
Pseudo R-squared 0.0127 0.0731 0.404 0.119 0.413
Notes: *** denotes signicance at 1%, ** at 5%, and * at 10% level. Observations are at the MSOA level.
Presence of existing hospital facilities is strongest determinant of ISP location
Adding PCT FE strengthens relationship with private hospital location. (OR increases
to 9.6 in col 4 and 138.7 in col 5)
Introduction Background Results Mechanisms Conclusions
Estimating a demand response
Within PCTs, relative distance to an ISP should not aect hip
replacement numbers through supply.
Placement related to nearest trust waiting times but not MSOA waiting
times (not related to local pre-existing need).
Administrative constraints should operate at PCT level, not MSOA level.
However, relative distance to an ISP should aect patient demand.
14/27
Table : Treatment and Control Group Denitions
Financial % MSOA % of MSOA hip rep % ISP pats
Year ISP close conducted by ISPs live close
ISP closer ISP Further
2003/4 2.7 1.1 0.1 35.0
2004/5 7.3 2.4 0.9 16.2
2005/6 8.6 3.9 1.9 17.9
2006/7 3.6 13.8 3.2 17.4
2007/8 12.8 13.8 5.6 29.2
2008/9 19.4 18.1 8.5 36.5
2009/10 22.3 17.7 10 36.8
2010/11 28.2 24.4 14.1 45.2
The proportion of areas treated by an ISP increases as more ISPs open
Patients are more likely to receive care from an ISP if they live in treated areas.
But, most ISP patients do not live in treated areas.
Introduction Background Results Mechanisms Conclusions
Fixed Eects Specication
Number of residents in MSOA m that receive a NHS-funded hip
replacement (conducted by an NHS trust or an ISP) in year t:
Hipsmt = α +βISPmt +γm + µt +Xmt +εmt (2)
The coecient of interest is β, the eect of introducing an ISP close to
MSOA m on number of residents admitted for NHS-funded hip
replacements.
Xmt includes time varying MSOA measures of population age
composition, admissions for fractured neck of femur, and the
unemployment rate. εmt clustered at the PCT level.
Identifying assumption: conditional on Xmt, ISPmt uncorrelated with εmt.
16/27
Table : Fixed eects estimates of the impact of ISP introduction on number of
admittances for elective hip replacements per MSOA
Type of ISP Closer: ISP ISTC AQP ISTC20 AQP20
(1) (2) (3) (4) (5)
ISP closer than nearest NHS Trust 0.222** 0.447 0.174* 1.189*** 0.825***
(0.0983) (0.326) (0.0976) (0.392) (0.168)
Pop 65-79 (thousands) 9.838*** 9.860*** 9.866*** 9.423*** 9.579***
(0.867) (0.863) (0.867) (0.860) (0.864)
Pop 80+ (thousands) 9.806*** 9.815*** 9.818*** 9.695*** 9.721***
(1.253) (1.255) (1.256) (1.256) (1.264)
FNOF admits 0.0581*** 0.0579*** 0.0581*** 0.0582*** 0.0586***
(0.0161) (0.0161) (0.0161) (0.0162) (0.0162)
FNOF admits squared -0.00377*** -0.00375*** -0.00376*** -0.00378*** -0.00377***
(0.00123) (0.00124) (0.00123) (0.00123) (0.00123)
Unemployment Rate -8.207 -8.176 -8.214 -9.216 -9.151
(6.126) (6.115) (6.134) (6.037) (6.082)
Year Fixed Eects Yes Yes Yes Yes Yes
MSOA Fixed Eects Yes Yes Yes Yes Yes
Demographics Yes Yes Yes Yes Yes
Observations 46,970 46,970 46,970 46,970 46,970
R-squared 0.121 0.121 0.121 0.123 0.124
Notes: *** denotes signicance at 1%, ** at 5%, and * at 10% level. Observations are at the MSOA year level. The dependent
variable in all columns is the number of admissions for an NHS-funded elective hip replacement amoungst MSOA residents.
Introduction Background Results Mechanisms Conclusions
Summary
The introduction of ISPs is associated with an increase in demand for
hip replacements.
For large ISPs introduced nearer than the nearest trust, ISTCs add 1.2
and AQPs 0.8 to annual hip replacements per MSOA.
Relative to a baseline level of hip replacements in 2003/04 of 7.
Equivalent to adding an additional 100 people aged 65+ to the MSOA
population.
Propensity score matching estimates provide a similar set of results.
Potential to use location of existing health care facilities as an IV.
18/27
Introduction Background Results Mechanisms Conclusions
Where is the additional demand for NHS treatment coming
from?
The increase in demand for hip replacements may operate through:
A rise in the number of people having hip replacements
Substitution from privately funded to NHS-funded hip replacements
Combine HES with hospital level data from the National Joint Registry
(NJR), to estimate relationships between NHS, ISP and private pay
volumes.
Caution: much more work needed on separating demand from supply.
19/27
Introduction Background Results Mechanisms Conclusions
Data Construction I
HES contains:
Number of patients treated in NHS hospitals
Number of NHS-funded patients treated in AQPs and ISTCs.
NJR contains:
Number of patient treated in NHS hospitals
Total number of patients treated in private hospitals, including those
operating as AQPs and ISTCs.
Private patients = Hip replacements in private hospitals (NJR) − hip
replacements conducted at ISTCs (NJR)− NHS-funded hip replacements
conducted by AQPs (HES)
Note: measurement error in the number of private procedures.
will be improved with access to patient level data (agreed in principle).
20/27
Introduction Background Results Mechanisms Conclusions
Data Construction II
The NJR has no information on where patients live, therefore assign
patients to areas on the basis of hospital location.
Collapse number of procedures by provider type and NHS/private pay by
Primary Care Trust and nancial year.
Use data from 2007/08 to 2010/11, due to concerns about quality of
data in earlier years.
Drop negative private pay volumes.
21/27
Introduction Background Results Mechanisms Conclusions
NJR-HES Sample
Table : PCTs that contain Independent Sector Providers and estimated privately
funded hip procedures 2007/08 to 2010/11
PCTs with ISPs No of hip reps on private sites
ISTCs AQPs All NHS-funded Est pr pay
NJR HES NJR  HES
2007/8 14 31 18,387 4,222 14,165
2008/9 19 48 22,198 6,794 15,404
2009/10 20 60 21,511 7,830 13,681
2010/11 22 77 22,975 11,665 11,310
Private hospitals treated more patients in 2010/11 than 2007/08.
Increased numbers of NHS-funded patients compensated for falls in private pay
patients.
22/27
Introduction Background Results Mechanisms Conclusions
Estimation
Private pay hip replacements and ISTCs
We assume that the supply of ISTC hips is determined by the ISTC
contract and therefore does not respond to private pay volumes.
Private pay hip operations in PCT p and nancial year t is given by:
PPHipspt = α +ρISTCpatspt +γp + µt +Zpt +εpt (3)
Private pay hip replacements and AQPs
We assume that private hospitals strictly prefer to treat private patients
over NHS-funded patients because they receive more for their care.
AQPpatspt = α +σPPHipspt +γp + µt +Zpt +εpt (4)
23/27
Table : Fixed eects estimates of the impact of ISP introduction on number of
admittances for elective hip replacements per PCT of treatment
Priv Funded Ops AQP NHS Ops NHS Trust Ops
(1) (2) (3) (4) (5) (6)
HES ISTC hips -0.155 -0.149 -0.147** -0.144**
(0.0995) (0.0958) (0.0628) (0.0618)
Est private pay hips -0.664*** -0.338***
(0.141) (0.0842)
HES AQP hips -0.0749 -0.207*
(0.0653) (0.109)
Sample All Balanced All Balanced All Balanced
PCT  Year FE Yes Yes Yes Yes Yes Yes
Age Composition Yes Yes Yes Yes Yes Yes
Observations 515 484 515 484 532 520
R-squared 0.112 0.165 0.664 0.484 0.043 0.052
Number of PCTs 135 121 135 121 136 130
Notes: *** denotes signicance at 1%, ** at 5%, and * at 10% level. Observations are at the PCT year level.
Strong evidence of substitution between private pay and AQP procedures, but not
between private pay and ISTC procedures.
Small negative eects of ISTC and AQP procedures on NHS trust procedure numbers
Introduction Background Results Mechanisms Conclusions
Summary
Number of NHS-funded hip replacements increased by 40% between
2003/04 and 2010/11, with ISPs accounting for almost two-thirds of the
rise.
Hip replacements increased faster in areas that were closer to an ISP
than the nearest NHS trust.
Fixed eects and matching estimates suggest that this was consistent
with a demand response.
Data on private pay patients from the NJR indicates strong evidence of
substitution between private pay and NHS-funded AQP procedures.
Consistent with private hospitals treating NHS patients to help
compensate for a decline in demand from private patients.
Increases in ISTC and AQP procedures tend to reduce procedures
conducted by NHS trusts.
25/27
Introduction Background Results Mechanisms Conclusions
Implications
1 For patients
ISPs contributed two-thirds of the total increase in hip replacements,
contributing a substantive increase in supply.
Patients beneted more in areas located nearer to an ISP than the
nearest trust.
2 For ISPs
ISTC sites provided an unambiguous increase in revenue, as there is not
much evidence of substitution
For AQPs, NHS-funded patients have compensated for falls in demand
from private patients.
In the long run could ISPs crowd out private pay patients?
3 For NHS trusts.
There is some evidence that ISP operations led to a fall in NHS trust
operations.
Unclear what this means for NHS trust nances, given likely substitution
to other activity.
26/27
Introduction Background Results Mechanisms Conclusions
Future Work
Add data from 2011/12 and 2012/13.
Patient level data from the National Joint Registry (removing the need
to estimate private pay patients).
Use the presence of existing health care facilities as an instrument for
ISP location.
More theoretical and empirical work separating the supply of health care
from demand for health care.
27/27

Weitere ähnliche Inhalte

Andere mochten auch

Carol Propper: Reform and demand response in the NHS
Carol Propper: Reform and demand response in the NHS  Carol Propper: Reform and demand response in the NHS
Carol Propper: Reform and demand response in the NHS Nuffield Trust
 
John Macaskill-Smith: General practice models in New Zealand
John Macaskill-Smith: General practice models in New ZealandJohn Macaskill-Smith: General practice models in New Zealand
John Macaskill-Smith: General practice models in New ZealandNuffield Trust
 
Holly Holder & Ian Blunt: Integrated care pilot evaluation
Holly Holder & Ian Blunt: Integrated care pilot evaluationHolly Holder & Ian Blunt: Integrated care pilot evaluation
Holly Holder & Ian Blunt: Integrated care pilot evaluationNuffield Trust
 
Jon Sussex: Capacity, choice and private ownership
Jon Sussex: Capacity, choice and private ownership Jon Sussex: Capacity, choice and private ownership
Jon Sussex: Capacity, choice and private ownership Nuffield Trust
 
Gavin MacColl: Anticipatory care planning in primary care
Gavin MacColl: Anticipatory care planning in primary careGavin MacColl: Anticipatory care planning in primary care
Gavin MacColl: Anticipatory care planning in primary careNuffield Trust
 
Richard Disney: Questions on quality, choice and demand
Richard Disney: Questions on quality, choice and demandRichard Disney: Questions on quality, choice and demand
Richard Disney: Questions on quality, choice and demandNuffield Trust
 
Mayumi Hayashi: Lessons from Japan on social care reform
Mayumi Hayashi: Lessons from Japan on social care reformMayumi Hayashi: Lessons from Japan on social care reform
Mayumi Hayashi: Lessons from Japan on social care reformNuffield Trust
 
William Shrank: Payment reform activities at CMS
William Shrank: Payment reform activities at CMSWilliam Shrank: Payment reform activities at CMS
William Shrank: Payment reform activities at CMSNuffield Trust
 
Hugh Gravelle: The impact of care quality on patient choice
Hugh Gravelle: The impact of care quality on patient choiceHugh Gravelle: The impact of care quality on patient choice
Hugh Gravelle: The impact of care quality on patient choiceNuffield Trust
 
Ian Duncan: Predictive risk in a US pharmacy
Ian Duncan: Predictive risk in a US pharmacyIan Duncan: Predictive risk in a US pharmacy
Ian Duncan: Predictive risk in a US pharmacyNuffield Trust
 
Paul Burstow: The need for care reform in England
Paul Burstow: The need for care reform in EnglandPaul Burstow: The need for care reform in England
Paul Burstow: The need for care reform in EnglandNuffield Trust
 
Elaine Kelly public payment and private provision
Elaine Kelly public payment and private provisionElaine Kelly public payment and private provision
Elaine Kelly public payment and private provisionNuffield Trust
 
Masahiko Hayashi: Long-term care insurance in Japan
Masahiko Hayashi: Long-term care insurance in JapanMasahiko Hayashi: Long-term care insurance in Japan
Masahiko Hayashi: Long-term care insurance in JapanNuffield Trust
 
Judith Smith: Commissioning for long-term conditions
Judith Smith: Commissioning for long-term conditionsJudith Smith: Commissioning for long-term conditions
Judith Smith: Commissioning for long-term conditionsNuffield Trust
 
Primary care in Europe: can we make it fit for the future?
Primary care in Europe: can we make it fit for the future?Primary care in Europe: can we make it fit for the future?
Primary care in Europe: can we make it fit for the future?Nuffield Trust
 
John Billings: Developing a new predictive risk model
John Billings: Developing a new predictive risk modelJohn Billings: Developing a new predictive risk model
John Billings: Developing a new predictive risk modelNuffield Trust
 
Andrew Street: Market mechanisms in health care
Andrew Street: Market mechanisms in health care Andrew Street: Market mechanisms in health care
Andrew Street: Market mechanisms in health care Nuffield Trust
 
Adam Steventon: How can predictive risk models help?
Adam Steventon: How can predictive risk models help?Adam Steventon: How can predictive risk models help?
Adam Steventon: How can predictive risk models help?Nuffield Trust
 
Tom Youldon: Creating a fair playing field
Tom Youldon: Creating a fair playing fieldTom Youldon: Creating a fair playing field
Tom Youldon: Creating a fair playing fieldNuffield Trust
 
Matt James: Choice and independent hospitals
Matt James: Choice and independent hospitalsMatt James: Choice and independent hospitals
Matt James: Choice and independent hospitalsNuffield Trust
 

Andere mochten auch (20)

Carol Propper: Reform and demand response in the NHS
Carol Propper: Reform and demand response in the NHS  Carol Propper: Reform and demand response in the NHS
Carol Propper: Reform and demand response in the NHS
 
John Macaskill-Smith: General practice models in New Zealand
John Macaskill-Smith: General practice models in New ZealandJohn Macaskill-Smith: General practice models in New Zealand
John Macaskill-Smith: General practice models in New Zealand
 
Holly Holder & Ian Blunt: Integrated care pilot evaluation
Holly Holder & Ian Blunt: Integrated care pilot evaluationHolly Holder & Ian Blunt: Integrated care pilot evaluation
Holly Holder & Ian Blunt: Integrated care pilot evaluation
 
Jon Sussex: Capacity, choice and private ownership
Jon Sussex: Capacity, choice and private ownership Jon Sussex: Capacity, choice and private ownership
Jon Sussex: Capacity, choice and private ownership
 
Gavin MacColl: Anticipatory care planning in primary care
Gavin MacColl: Anticipatory care planning in primary careGavin MacColl: Anticipatory care planning in primary care
Gavin MacColl: Anticipatory care planning in primary care
 
Richard Disney: Questions on quality, choice and demand
Richard Disney: Questions on quality, choice and demandRichard Disney: Questions on quality, choice and demand
Richard Disney: Questions on quality, choice and demand
 
Mayumi Hayashi: Lessons from Japan on social care reform
Mayumi Hayashi: Lessons from Japan on social care reformMayumi Hayashi: Lessons from Japan on social care reform
Mayumi Hayashi: Lessons from Japan on social care reform
 
William Shrank: Payment reform activities at CMS
William Shrank: Payment reform activities at CMSWilliam Shrank: Payment reform activities at CMS
William Shrank: Payment reform activities at CMS
 
Hugh Gravelle: The impact of care quality on patient choice
Hugh Gravelle: The impact of care quality on patient choiceHugh Gravelle: The impact of care quality on patient choice
Hugh Gravelle: The impact of care quality on patient choice
 
Ian Duncan: Predictive risk in a US pharmacy
Ian Duncan: Predictive risk in a US pharmacyIan Duncan: Predictive risk in a US pharmacy
Ian Duncan: Predictive risk in a US pharmacy
 
Paul Burstow: The need for care reform in England
Paul Burstow: The need for care reform in EnglandPaul Burstow: The need for care reform in England
Paul Burstow: The need for care reform in England
 
Elaine Kelly public payment and private provision
Elaine Kelly public payment and private provisionElaine Kelly public payment and private provision
Elaine Kelly public payment and private provision
 
Masahiko Hayashi: Long-term care insurance in Japan
Masahiko Hayashi: Long-term care insurance in JapanMasahiko Hayashi: Long-term care insurance in Japan
Masahiko Hayashi: Long-term care insurance in Japan
 
Judith Smith: Commissioning for long-term conditions
Judith Smith: Commissioning for long-term conditionsJudith Smith: Commissioning for long-term conditions
Judith Smith: Commissioning for long-term conditions
 
Primary care in Europe: can we make it fit for the future?
Primary care in Europe: can we make it fit for the future?Primary care in Europe: can we make it fit for the future?
Primary care in Europe: can we make it fit for the future?
 
John Billings: Developing a new predictive risk model
John Billings: Developing a new predictive risk modelJohn Billings: Developing a new predictive risk model
John Billings: Developing a new predictive risk model
 
Andrew Street: Market mechanisms in health care
Andrew Street: Market mechanisms in health care Andrew Street: Market mechanisms in health care
Andrew Street: Market mechanisms in health care
 
Adam Steventon: How can predictive risk models help?
Adam Steventon: How can predictive risk models help?Adam Steventon: How can predictive risk models help?
Adam Steventon: How can predictive risk models help?
 
Tom Youldon: Creating a fair playing field
Tom Youldon: Creating a fair playing fieldTom Youldon: Creating a fair playing field
Tom Youldon: Creating a fair playing field
 
Matt James: Choice and independent hospitals
Matt James: Choice and independent hospitalsMatt James: Choice and independent hospitals
Matt James: Choice and independent hospitals
 

Ähnlich wie Elaine Kelly: Growth in NHS-funded elective care

State of the Musculoskeletal Service Line: What's New in 2013 and Beyond?
State of the Musculoskeletal Service Line: What's New in 2013 and Beyond?State of the Musculoskeletal Service Line: What's New in 2013 and Beyond?
State of the Musculoskeletal Service Line: What's New in 2013 and Beyond?Wellbe
 
GIRFT-Executive-Summary-Mar15
GIRFT-Executive-Summary-Mar15GIRFT-Executive-Summary-Mar15
GIRFT-Executive-Summary-Mar15John Machin
 
Elaine kelly public payment and private provision
Elaine kelly public payment and private provisionElaine kelly public payment and private provision
Elaine kelly public payment and private provisionNuffield Trust
 
Billing Transition in Medical Imaging - a 2010 presentation by Rob Maroszek
Billing Transition in Medical Imaging - a 2010 presentation by Rob MaroszekBilling Transition in Medical Imaging - a 2010 presentation by Rob Maroszek
Billing Transition in Medical Imaging - a 2010 presentation by Rob MaroszekRobert P. Maroszek
 
The Joint Replacement Bundle: Implications for Patients and Acute Pain Services
The Joint Replacement Bundle: Implications for Patients and Acute Pain ServicesThe Joint Replacement Bundle: Implications for Patients and Acute Pain Services
The Joint Replacement Bundle: Implications for Patients and Acute Pain ServicesEdward R. Mariano, MD
 
Physician-Hospital Integration Strategies to Maximize the Bottom Line for Ort...
Physician-Hospital Integration Strategies to Maximize the Bottom Line for Ort...Physician-Hospital Integration Strategies to Maximize the Bottom Line for Ort...
Physician-Hospital Integration Strategies to Maximize the Bottom Line for Ort...Wellbe
 
Financial Implications for Integrating Carestream OnSight 3D Extremity System...
Financial Implications for Integrating Carestream OnSight 3D Extremity System...Financial Implications for Integrating Carestream OnSight 3D Extremity System...
Financial Implications for Integrating Carestream OnSight 3D Extremity System...Carestream
 
Mapping the market
Mapping the marketMapping the market
Mapping the marketCogora
 
Experiences from State Health System Development Project.ppt
Experiences from State Health System Development Project.pptExperiences from State Health System Development Project.ppt
Experiences from State Health System Development Project.pptsuvadeepde
 
4HS440 Finance for HealthcareUnit 7Assignment Numeric Problems.docx
4HS440 Finance for HealthcareUnit 7Assignment Numeric Problems.docx4HS440 Finance for HealthcareUnit 7Assignment Numeric Problems.docx
4HS440 Finance for HealthcareUnit 7Assignment Numeric Problems.docxgilbertkpeters11344
 
Plenary_Talk_1_Meyer
Plenary_Talk_1_MeyerPlenary_Talk_1_Meyer
Plenary_Talk_1_MeyerCSS-Institute
 
S4 p+orthopedic+market+overview 2019
S4 p+orthopedic+market+overview 2019S4 p+orthopedic+market+overview 2019
S4 p+orthopedic+market+overview 2019~Eric Principe
 

Ähnlich wie Elaine Kelly: Growth in NHS-funded elective care (20)

State of the Musculoskeletal Service Line: What's New in 2013 and Beyond?
State of the Musculoskeletal Service Line: What's New in 2013 and Beyond?State of the Musculoskeletal Service Line: What's New in 2013 and Beyond?
State of the Musculoskeletal Service Line: What's New in 2013 and Beyond?
 
Focus on cataract
Focus on cataractFocus on cataract
Focus on cataract
 
GIRFT-Executive-Summary-Mar15
GIRFT-Executive-Summary-Mar15GIRFT-Executive-Summary-Mar15
GIRFT-Executive-Summary-Mar15
 
Elaine kelly public payment and private provision
Elaine kelly public payment and private provisionElaine kelly public payment and private provision
Elaine kelly public payment and private provision
 
Billing Transition in Medical Imaging - a 2010 presentation by Rob Maroszek
Billing Transition in Medical Imaging - a 2010 presentation by Rob MaroszekBilling Transition in Medical Imaging - a 2010 presentation by Rob Maroszek
Billing Transition in Medical Imaging - a 2010 presentation by Rob Maroszek
 
Reintroductioncompetition
ReintroductioncompetitionReintroductioncompetition
Reintroductioncompetition
 
The Joint Replacement Bundle: Implications for Patients and Acute Pain Services
The Joint Replacement Bundle: Implications for Patients and Acute Pain ServicesThe Joint Replacement Bundle: Implications for Patients and Acute Pain Services
The Joint Replacement Bundle: Implications for Patients and Acute Pain Services
 
Physician-Hospital Integration Strategies to Maximize the Bottom Line for Ort...
Physician-Hospital Integration Strategies to Maximize the Bottom Line for Ort...Physician-Hospital Integration Strategies to Maximize the Bottom Line for Ort...
Physician-Hospital Integration Strategies to Maximize the Bottom Line for Ort...
 
Gaynor.slides.10.22.10
Gaynor.slides.10.22.10Gaynor.slides.10.22.10
Gaynor.slides.10.22.10
 
Tim Briggs
Tim BriggsTim Briggs
Tim Briggs
 
NHS Car Parking
NHS Car ParkingNHS Car Parking
NHS Car Parking
 
Financial Implications for Integrating Carestream OnSight 3D Extremity System...
Financial Implications for Integrating Carestream OnSight 3D Extremity System...Financial Implications for Integrating Carestream OnSight 3D Extremity System...
Financial Implications for Integrating Carestream OnSight 3D Extremity System...
 
Mapping the market
Mapping the marketMapping the market
Mapping the market
 
Benefits case study summary: Diabetes Uk Putting Feet First Campaign
Benefits case study summary: Diabetes Uk Putting Feet First CampaignBenefits case study summary: Diabetes Uk Putting Feet First Campaign
Benefits case study summary: Diabetes Uk Putting Feet First Campaign
 
Experiences from State Health System Development Project.ppt
Experiences from State Health System Development Project.pptExperiences from State Health System Development Project.ppt
Experiences from State Health System Development Project.ppt
 
4HS440 Finance for HealthcareUnit 7Assignment Numeric Problems.docx
4HS440 Finance for HealthcareUnit 7Assignment Numeric Problems.docx4HS440 Finance for HealthcareUnit 7Assignment Numeric Problems.docx
4HS440 Finance for HealthcareUnit 7Assignment Numeric Problems.docx
 
Benefits case study: Diabetes UK Putting Feet First Campaign
Benefits case study: Diabetes UK Putting Feet First CampaignBenefits case study: Diabetes UK Putting Feet First Campaign
Benefits case study: Diabetes UK Putting Feet First Campaign
 
Plenary_Talk_1_Meyer
Plenary_Talk_1_MeyerPlenary_Talk_1_Meyer
Plenary_Talk_1_Meyer
 
S4 p+orthopedic+market+overview 2019
S4 p+orthopedic+market+overview 2019S4 p+orthopedic+market+overview 2019
S4 p+orthopedic+market+overview 2019
 
HSC report.pptx
HSC report.pptxHSC report.pptx
HSC report.pptx
 

Mehr von Nuffield Trust

Transforming outpatient services - Nuffield Trust/NHS Improvement Event
Transforming outpatient services - Nuffield Trust/NHS Improvement EventTransforming outpatient services - Nuffield Trust/NHS Improvement Event
Transforming outpatient services - Nuffield Trust/NHS Improvement EventNuffield Trust
 
13 reasons to spend more on health and social care
13 reasons to spend more on health and social care 13 reasons to spend more on health and social care
13 reasons to spend more on health and social care Nuffield Trust
 
Energising your workforce in the face of adversity
Energising your workforce in the face of adversityEnergising your workforce in the face of adversity
Energising your workforce in the face of adversityNuffield Trust
 
Shifting the balance of care: great expectations
Shifting the balance of care: great expectations Shifting the balance of care: great expectations
Shifting the balance of care: great expectations Nuffield Trust
 
Automation, Employment, and Health Care
Automation, Employment, and Health Care Automation, Employment, and Health Care
Automation, Employment, and Health Care Nuffield Trust
 
Public perspectives on the NHS and social care
Public perspectives on the NHS and social carePublic perspectives on the NHS and social care
Public perspectives on the NHS and social careNuffield Trust
 
Evaluation of the Integrated Care and Support Pioneers Programme
Evaluation of the Integrated Care and Support Pioneers ProgrammeEvaluation of the Integrated Care and Support Pioneers Programme
Evaluation of the Integrated Care and Support Pioneers ProgrammeNuffield Trust
 
Ensuring success for new models of care
Ensuring success for new models of careEnsuring success for new models of care
Ensuring success for new models of careNuffield Trust
 
Effectiveness of the current dominant approach to integrated care in the NHS
Effectiveness of the current dominant approach to integrated care in the NHSEffectiveness of the current dominant approach to integrated care in the NHS
Effectiveness of the current dominant approach to integrated care in the NHSNuffield Trust
 
Providing actionable healthcare analytics at scale: Understanding improvement...
Providing actionable healthcare analytics at scale: Understanding improvement...Providing actionable healthcare analytics at scale: Understanding improvement...
Providing actionable healthcare analytics at scale: Understanding improvement...Nuffield Trust
 
Local and national uses of data
Local and national uses of dataLocal and national uses of data
Local and national uses of dataNuffield Trust
 
Applied use of CUSUMs in surveillance
Applied use of CUSUMs in surveillanceApplied use of CUSUMs in surveillance
Applied use of CUSUMs in surveillanceNuffield Trust
 
Evaluating new models of care: Improvement Analytics Unit
Evaluating new models of care: Improvement Analytics UnitEvaluating new models of care: Improvement Analytics Unit
Evaluating new models of care: Improvement Analytics UnitNuffield Trust
 
Learning from the Care Quality Commission
Learning from the Care Quality CommissionLearning from the Care Quality Commission
Learning from the Care Quality CommissionNuffield Trust
 
Real-time monitoring and the data trap
Real-time monitoring and the data trapReal-time monitoring and the data trap
Real-time monitoring and the data trapNuffield Trust
 
Monitoring quality of care: making the most of data
Monitoring quality of care: making the most of dataMonitoring quality of care: making the most of data
Monitoring quality of care: making the most of dataNuffield Trust
 
Providing actionable healthcare analytics at scale: Insights from the Nationa...
Providing actionable healthcare analytics at scale: Insights from the Nationa...Providing actionable healthcare analytics at scale: Insights from the Nationa...
Providing actionable healthcare analytics at scale: Insights from the Nationa...Nuffield Trust
 
Providing actionable healthcare analytics at scale: A perspective from stroke...
Providing actionable healthcare analytics at scale: A perspective from stroke...Providing actionable healthcare analytics at scale: A perspective from stroke...
Providing actionable healthcare analytics at scale: A perspective from stroke...Nuffield Trust
 
New Models of General Practice: Practical and policy lessons
New Models of General Practice: Practical and policy lessonsNew Models of General Practice: Practical and policy lessons
New Models of General Practice: Practical and policy lessonsNuffield Trust
 

Mehr von Nuffield Trust (20)

Transforming outpatient services - Nuffield Trust/NHS Improvement Event
Transforming outpatient services - Nuffield Trust/NHS Improvement EventTransforming outpatient services - Nuffield Trust/NHS Improvement Event
Transforming outpatient services - Nuffield Trust/NHS Improvement Event
 
13 reasons to spend more on health and social care
13 reasons to spend more on health and social care 13 reasons to spend more on health and social care
13 reasons to spend more on health and social care
 
Energising your workforce in the face of adversity
Energising your workforce in the face of adversityEnergising your workforce in the face of adversity
Energising your workforce in the face of adversity
 
Shifting the balance of care: great expectations
Shifting the balance of care: great expectations Shifting the balance of care: great expectations
Shifting the balance of care: great expectations
 
Automation, Employment, and Health Care
Automation, Employment, and Health Care Automation, Employment, and Health Care
Automation, Employment, and Health Care
 
Public perspectives on the NHS and social care
Public perspectives on the NHS and social carePublic perspectives on the NHS and social care
Public perspectives on the NHS and social care
 
Evaluation of the Integrated Care and Support Pioneers Programme
Evaluation of the Integrated Care and Support Pioneers ProgrammeEvaluation of the Integrated Care and Support Pioneers Programme
Evaluation of the Integrated Care and Support Pioneers Programme
 
Ensuring success for new models of care
Ensuring success for new models of careEnsuring success for new models of care
Ensuring success for new models of care
 
Effectiveness of the current dominant approach to integrated care in the NHS
Effectiveness of the current dominant approach to integrated care in the NHSEffectiveness of the current dominant approach to integrated care in the NHS
Effectiveness of the current dominant approach to integrated care in the NHS
 
Providing actionable healthcare analytics at scale: Understanding improvement...
Providing actionable healthcare analytics at scale: Understanding improvement...Providing actionable healthcare analytics at scale: Understanding improvement...
Providing actionable healthcare analytics at scale: Understanding improvement...
 
Local and national uses of data
Local and national uses of dataLocal and national uses of data
Local and national uses of data
 
Applied use of CUSUMs in surveillance
Applied use of CUSUMs in surveillanceApplied use of CUSUMs in surveillance
Applied use of CUSUMs in surveillance
 
Engaging with data
Engaging with dataEngaging with data
Engaging with data
 
Evaluating new models of care: Improvement Analytics Unit
Evaluating new models of care: Improvement Analytics UnitEvaluating new models of care: Improvement Analytics Unit
Evaluating new models of care: Improvement Analytics Unit
 
Learning from the Care Quality Commission
Learning from the Care Quality CommissionLearning from the Care Quality Commission
Learning from the Care Quality Commission
 
Real-time monitoring and the data trap
Real-time monitoring and the data trapReal-time monitoring and the data trap
Real-time monitoring and the data trap
 
Monitoring quality of care: making the most of data
Monitoring quality of care: making the most of dataMonitoring quality of care: making the most of data
Monitoring quality of care: making the most of data
 
Providing actionable healthcare analytics at scale: Insights from the Nationa...
Providing actionable healthcare analytics at scale: Insights from the Nationa...Providing actionable healthcare analytics at scale: Insights from the Nationa...
Providing actionable healthcare analytics at scale: Insights from the Nationa...
 
Providing actionable healthcare analytics at scale: A perspective from stroke...
Providing actionable healthcare analytics at scale: A perspective from stroke...Providing actionable healthcare analytics at scale: A perspective from stroke...
Providing actionable healthcare analytics at scale: A perspective from stroke...
 
New Models of General Practice: Practical and policy lessons
New Models of General Practice: Practical and policy lessonsNew Models of General Practice: Practical and policy lessons
New Models of General Practice: Practical and policy lessons
 

Kürzlich hochgeladen

Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.aarjukhadka22
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxMAsifAhmad
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsMedicoseAcademics
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdfHongBiThi1
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionkrishnareddy157915
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfHongBiThi1
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu Medical University
 
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfSGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfHongBiThi1
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentsaileshpanda05
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.kishan singh tomar
 
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...Sujoy Dasgupta
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyMedicoseAcademics
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdfHongBiThi1
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project reportNARMADAPETROLEUMGAS
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyZurück zum Ursprung
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptPradnya Wadekar
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptxWINCY THIRUMURUGAN
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptxNIKITA BHUTE
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisSujoy Dasgupta
 

Kürzlich hochgeladen (20)

Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functions
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung function
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
 
Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu
 
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfSGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing student
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.
 
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before Pregnancy
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project report
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturally
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologyppt
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosis
 

Elaine Kelly: Growth in NHS-funded elective care

  • 1. Introduction Background Results Mechanisms Conclusions More hips, please. Independent sector provision and the growth in NHS-funded elective care Elaine Kelly & George Stoye Nueld Trust Workshop 13th September 2013 1/27
  • 2. Introduction Background Results Mechanisms Conclusions Introduction The past decade of health care policy reforms have increased the role of competition in NHS-funded care. Existing work has concentrated on the patient choice reforms of 2006 and 2008. [Cooper et al, 2011; Gaynor et al, 2012 a,b] This paper focuses on a separate but related set of reforms that increased the access of independent sector providers (ISP) to markets for NHS-funded elective secondary care. How did this aect the market for both NHS and privately funded hip replacements? 2/27
  • 3. Figure : Total number of NHS-funded hip replacements in England, by provider type 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 HipReplacements Financial Year ISP NHS Trusts The total number of NHS-funded hip replacements increased by 40% between 2003/04 and 2010/11. After 2006/07, most of this growth is accounted for by ISPs.
  • 4. Figure : Mean hip NHS-funded replacements per Middle Super Output Area by nearest provider type in 2010/11 6 6.5 7 7.5 8 8.5 9 9.5 10 10.5 11 2003/4 2004/5 2005/6 2006/7 2007/8 2008/9 2009/10 2010/11 MeanhipreplacementsperMOSA/year NHS ISP Growth was fastest in areas where an ISP was located closer than the nearest NHS trust by 2010/11.
  • 5. Introduction Background Results Mechanisms Conclusions Research Questions How did the introduction of ISPs aect the market for NHS-funded hip replacements? 1 Why did the number of hip replacements increase faster in areas where ISPs were located relatively close by? 2 What explains the increase in the number of NHS-funded hip replacements? New procedures Substitution from privately funded procedures 5/27
  • 6. Introduction Background Results Mechanisms Conclusions Independent Sector Provider reforms 1 Independent Sector Treatment Centres (ISTCs) First introduced in 2003, expanded in 2006. Privately owned but typically treat just NHS-funded patients. Objectives [Naylor Gregory, 2009]: Wave 1: to address capacity constraints and reduce waiting times Wave 2: increasing competition for NHS providers, providing more choices for patients, and fostering innovation. 2 Any Qualied Providers (AQPs) In mid 2007, choice of providers in orthopaedics expanded to cover existing facilities, such as private hospitals, through the Extended Choice Network. Treat privately funded and NHS-funded patients. Extended to other specialties when 2nd choice reform was introduced in 2008. 6/27
  • 7. Figure : NHS-funded hip replacements conducted by ISPs, by quarter and ISP type 0500100015002000 NumberISPHipProcedures 2003q2 2004q2 2005q2 2006q2 2007q2 2008q2 2009q2 2010q2 2011q2 Time ISTC sites AQP sites ISTC volumes started to increase as ISTCs began to open. Levelled o after 2008. AQP volumes increased rapidly after the second choice reform was introduced.
  • 8. Figure : Number of ISP sites by year and ISP type 0 20 40 60 80 100 120 Sites 1 pat Sites 20 pats Sites 1 pat Sites 20 pats ISTC AQP NumberofISPSites 2003/4 2004/5 2005/6 2006/7 2007/8 2008/9 2009/10 2010/11 More AQP sites, but ISTC procedures more concentrated across sites. In 2010/11, average NHS-funded hip replacements per site were 65 for AQPs and 160 for ISTCs.
  • 9. Figure : Mean number of hip replacements per MSOA/year, by nearest provider type in 2010/11 6 6.5 7 7.5 8 8.5 9 9.5 10 10.5 11 2003/4 2004/5 2005/6 2006/7 2007/8 2008/9 2009/10 2010/11 MeanhipreplacementsperMSOA/year Financial Year NHS ISTC AQP Relative growth is much faster in areas where an ISTC is the nearest provider than where AQPs are the nearest provider. Shift in entire distribution, not just the mean.
  • 10. Introduction Background Results Mechanisms Conclusions Why might introducing ISPs aect the number of NHS-funded procedures? 1 Supply: extra potential capacity relaxes supply constraints. An initial objective of the ISTC programme [Naylor Gregory, 2009] 2 Demand: ISPs provide an option that potential patients prefer to: 1 No procedure. 2 Privately funded treatment This paper focuses on establishing whether there was a demand response. Diculty: all areas/patients can access ISPs through the 2008 choice reforms. Solution: exploit variation in intensity of treatment or exposure by relative distance between the nearest ISP and the nearest NHS trust. 10/27
  • 11. Introduction Background Results Mechanisms Conclusions Why does the growth rate of hip replacement vary by distance to ISP? 1 Endogenous placement: ISPs located in areas where higher growth is anticipated/removing supply constraints 2 A demand response: Patients prefer treatment closer to home [Beckert et al, 2012; Sivey 2012]. Analysis examines ISP placement and the number of hip replacements at the Middle Super Output Area (MSOA) level. Data on NHS-funded hip replacements from the inpatient Hospital Episode Statistics (HES). 6,710 MSOAs in England (ave pop 7,200). MSOAs are a statistical construct, no administrative jurisdictions. Dene MSOA as treated if there is an ISP that performs hip replacements nearer than the NHS trust. 11/27
  • 12. Introduction Background Results Mechanisms Conclusions What are the determinants of ISP placement? The odds of MSOA m having an ISP closer than the nearest NHS trust in 2010/11 is given by the following specication: ISPclose10m = θo +θ1WaitTimesm +θ2nTrustm +θ3SDm +em (1) WaitTimesm includes waiting times of nearest trust and residents of the MSOA, and MSOA admittances for hip replacements in 2003/04. nTrustm are characteristics of the nearest trust to MSOA m; SDm are socio-demographic characteristics (all pre 2005) Results aim to indicate: The extent to which ISP placement reects population need/supply constraints Any sources of random variation in placement that could be used for identication 12/27
  • 13. Table : Odds of having an ISP closer than the nearest NHS trust in 2010/11 Type of ISP Closer than the Nearest Trust ISP ISP ISP ISTC only AQP only (1) (2) (3) (4) (5) Nearest Trust Wait Time 2003 (SD) 1.352*** 1.195** 1.141 1.284 1.124 (0.102) (0.0900) (0.117) (0.272) (0.128) MSOA Wait Time 2003 (SD) 0.983 0.963 0.943 0.927 0.955 (0.0356) (0.0355) (0.0451) (0.0742) (0.0493) Average hip replacements in 2003 and 2004 0.972* 0.927*** 0.939** 1.013 0.938** (0.0159) (0.0176) (0.0242) (0.0370) (0.0257) Distance to Nearest Trust (km) 1.120*** 1.078*** 1.054 1.064** (0.0270) (0.0294) (0.0408) (0.0300) Distance to Nearest Trust Squared (km) 0.997*** 0.998** 0.999 0.999 (0.000760) (0.000768) (0.000941) (0.000789) IMD score (2004) 0.967*** 0.976 1.063*** 0.941*** (0.0117) (0.0179) (0.0185) (0.0198) Private hospital closer 29.25*** 3.573*** 33.56*** (7.843) (1.292) (9.935) NHS `hospital' (30 beds) closer 2.028*** 2.146*** 1.915*** (0.384) (0.624) (0.386) Nearest trust Socio-demographics No Yes Yes Yes Yes Observations 6,710 6,710 6,710 6,710 6,710 Pseudo R-squared 0.0127 0.0731 0.404 0.119 0.413 Notes: *** denotes signicance at 1%, ** at 5%, and * at 10% level. Observations are at the MSOA level. Presence of existing hospital facilities is strongest determinant of ISP location Adding PCT FE strengthens relationship with private hospital location. (OR increases to 9.6 in col 4 and 138.7 in col 5)
  • 14. Introduction Background Results Mechanisms Conclusions Estimating a demand response Within PCTs, relative distance to an ISP should not aect hip replacement numbers through supply. Placement related to nearest trust waiting times but not MSOA waiting times (not related to local pre-existing need). Administrative constraints should operate at PCT level, not MSOA level. However, relative distance to an ISP should aect patient demand. 14/27
  • 15. Table : Treatment and Control Group Denitions Financial % MSOA % of MSOA hip rep % ISP pats Year ISP close conducted by ISPs live close ISP closer ISP Further 2003/4 2.7 1.1 0.1 35.0 2004/5 7.3 2.4 0.9 16.2 2005/6 8.6 3.9 1.9 17.9 2006/7 3.6 13.8 3.2 17.4 2007/8 12.8 13.8 5.6 29.2 2008/9 19.4 18.1 8.5 36.5 2009/10 22.3 17.7 10 36.8 2010/11 28.2 24.4 14.1 45.2 The proportion of areas treated by an ISP increases as more ISPs open Patients are more likely to receive care from an ISP if they live in treated areas. But, most ISP patients do not live in treated areas.
  • 16. Introduction Background Results Mechanisms Conclusions Fixed Eects Specication Number of residents in MSOA m that receive a NHS-funded hip replacement (conducted by an NHS trust or an ISP) in year t: Hipsmt = α +βISPmt +γm + µt +Xmt +εmt (2) The coecient of interest is β, the eect of introducing an ISP close to MSOA m on number of residents admitted for NHS-funded hip replacements. Xmt includes time varying MSOA measures of population age composition, admissions for fractured neck of femur, and the unemployment rate. εmt clustered at the PCT level. Identifying assumption: conditional on Xmt, ISPmt uncorrelated with εmt. 16/27
  • 17. Table : Fixed eects estimates of the impact of ISP introduction on number of admittances for elective hip replacements per MSOA Type of ISP Closer: ISP ISTC AQP ISTC20 AQP20 (1) (2) (3) (4) (5) ISP closer than nearest NHS Trust 0.222** 0.447 0.174* 1.189*** 0.825*** (0.0983) (0.326) (0.0976) (0.392) (0.168) Pop 65-79 (thousands) 9.838*** 9.860*** 9.866*** 9.423*** 9.579*** (0.867) (0.863) (0.867) (0.860) (0.864) Pop 80+ (thousands) 9.806*** 9.815*** 9.818*** 9.695*** 9.721*** (1.253) (1.255) (1.256) (1.256) (1.264) FNOF admits 0.0581*** 0.0579*** 0.0581*** 0.0582*** 0.0586*** (0.0161) (0.0161) (0.0161) (0.0162) (0.0162) FNOF admits squared -0.00377*** -0.00375*** -0.00376*** -0.00378*** -0.00377*** (0.00123) (0.00124) (0.00123) (0.00123) (0.00123) Unemployment Rate -8.207 -8.176 -8.214 -9.216 -9.151 (6.126) (6.115) (6.134) (6.037) (6.082) Year Fixed Eects Yes Yes Yes Yes Yes MSOA Fixed Eects Yes Yes Yes Yes Yes Demographics Yes Yes Yes Yes Yes Observations 46,970 46,970 46,970 46,970 46,970 R-squared 0.121 0.121 0.121 0.123 0.124 Notes: *** denotes signicance at 1%, ** at 5%, and * at 10% level. Observations are at the MSOA year level. The dependent variable in all columns is the number of admissions for an NHS-funded elective hip replacement amoungst MSOA residents.
  • 18. Introduction Background Results Mechanisms Conclusions Summary The introduction of ISPs is associated with an increase in demand for hip replacements. For large ISPs introduced nearer than the nearest trust, ISTCs add 1.2 and AQPs 0.8 to annual hip replacements per MSOA. Relative to a baseline level of hip replacements in 2003/04 of 7. Equivalent to adding an additional 100 people aged 65+ to the MSOA population. Propensity score matching estimates provide a similar set of results. Potential to use location of existing health care facilities as an IV. 18/27
  • 19. Introduction Background Results Mechanisms Conclusions Where is the additional demand for NHS treatment coming from? The increase in demand for hip replacements may operate through: A rise in the number of people having hip replacements Substitution from privately funded to NHS-funded hip replacements Combine HES with hospital level data from the National Joint Registry (NJR), to estimate relationships between NHS, ISP and private pay volumes. Caution: much more work needed on separating demand from supply. 19/27
  • 20. Introduction Background Results Mechanisms Conclusions Data Construction I HES contains: Number of patients treated in NHS hospitals Number of NHS-funded patients treated in AQPs and ISTCs. NJR contains: Number of patient treated in NHS hospitals Total number of patients treated in private hospitals, including those operating as AQPs and ISTCs. Private patients = Hip replacements in private hospitals (NJR) − hip replacements conducted at ISTCs (NJR)− NHS-funded hip replacements conducted by AQPs (HES) Note: measurement error in the number of private procedures. will be improved with access to patient level data (agreed in principle). 20/27
  • 21. Introduction Background Results Mechanisms Conclusions Data Construction II The NJR has no information on where patients live, therefore assign patients to areas on the basis of hospital location. Collapse number of procedures by provider type and NHS/private pay by Primary Care Trust and nancial year. Use data from 2007/08 to 2010/11, due to concerns about quality of data in earlier years. Drop negative private pay volumes. 21/27
  • 22. Introduction Background Results Mechanisms Conclusions NJR-HES Sample Table : PCTs that contain Independent Sector Providers and estimated privately funded hip procedures 2007/08 to 2010/11 PCTs with ISPs No of hip reps on private sites ISTCs AQPs All NHS-funded Est pr pay NJR HES NJR HES 2007/8 14 31 18,387 4,222 14,165 2008/9 19 48 22,198 6,794 15,404 2009/10 20 60 21,511 7,830 13,681 2010/11 22 77 22,975 11,665 11,310 Private hospitals treated more patients in 2010/11 than 2007/08. Increased numbers of NHS-funded patients compensated for falls in private pay patients. 22/27
  • 23. Introduction Background Results Mechanisms Conclusions Estimation Private pay hip replacements and ISTCs We assume that the supply of ISTC hips is determined by the ISTC contract and therefore does not respond to private pay volumes. Private pay hip operations in PCT p and nancial year t is given by: PPHipspt = α +ρISTCpatspt +γp + µt +Zpt +εpt (3) Private pay hip replacements and AQPs We assume that private hospitals strictly prefer to treat private patients over NHS-funded patients because they receive more for their care. AQPpatspt = α +σPPHipspt +γp + µt +Zpt +εpt (4) 23/27
  • 24. Table : Fixed eects estimates of the impact of ISP introduction on number of admittances for elective hip replacements per PCT of treatment Priv Funded Ops AQP NHS Ops NHS Trust Ops (1) (2) (3) (4) (5) (6) HES ISTC hips -0.155 -0.149 -0.147** -0.144** (0.0995) (0.0958) (0.0628) (0.0618) Est private pay hips -0.664*** -0.338*** (0.141) (0.0842) HES AQP hips -0.0749 -0.207* (0.0653) (0.109) Sample All Balanced All Balanced All Balanced PCT Year FE Yes Yes Yes Yes Yes Yes Age Composition Yes Yes Yes Yes Yes Yes Observations 515 484 515 484 532 520 R-squared 0.112 0.165 0.664 0.484 0.043 0.052 Number of PCTs 135 121 135 121 136 130 Notes: *** denotes signicance at 1%, ** at 5%, and * at 10% level. Observations are at the PCT year level. Strong evidence of substitution between private pay and AQP procedures, but not between private pay and ISTC procedures. Small negative eects of ISTC and AQP procedures on NHS trust procedure numbers
  • 25. Introduction Background Results Mechanisms Conclusions Summary Number of NHS-funded hip replacements increased by 40% between 2003/04 and 2010/11, with ISPs accounting for almost two-thirds of the rise. Hip replacements increased faster in areas that were closer to an ISP than the nearest NHS trust. Fixed eects and matching estimates suggest that this was consistent with a demand response. Data on private pay patients from the NJR indicates strong evidence of substitution between private pay and NHS-funded AQP procedures. Consistent with private hospitals treating NHS patients to help compensate for a decline in demand from private patients. Increases in ISTC and AQP procedures tend to reduce procedures conducted by NHS trusts. 25/27
  • 26. Introduction Background Results Mechanisms Conclusions Implications 1 For patients ISPs contributed two-thirds of the total increase in hip replacements, contributing a substantive increase in supply. Patients beneted more in areas located nearer to an ISP than the nearest trust. 2 For ISPs ISTC sites provided an unambiguous increase in revenue, as there is not much evidence of substitution For AQPs, NHS-funded patients have compensated for falls in demand from private patients. In the long run could ISPs crowd out private pay patients? 3 For NHS trusts. There is some evidence that ISP operations led to a fall in NHS trust operations. Unclear what this means for NHS trust nances, given likely substitution to other activity. 26/27
  • 27. Introduction Background Results Mechanisms Conclusions Future Work Add data from 2011/12 and 2012/13. Patient level data from the National Joint Registry (removing the need to estimate private pay patients). Use the presence of existing health care facilities as an instrument for ISP location. More theoretical and empirical work separating the supply of health care from demand for health care. 27/27